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Debating the Clinical Significance of Dyssynchrony
In this issue, two invited viewpoint articles address the clinical utility of variousmeasurements of myocardial dyssynchrony. Kass argues that many of the current
techniques used to diagnose dyssynchrony aremore amanifestation of the fact that the
heart is not a symmetric or simple pump and is subject to a variety of insults, most of
which will not benefit from cardiac resynchronization therapy (CRT). Nagueh agrees
with someof these points, but argues thatwhendefined appropriately, severalmeasures
of dyssynchrony identify patients at risk for worse outcomes, in whom a more
aggressive approach, possibly includingCRT, seemswarranted.Relying solely onQRS
prolongation and substantial reductions in ejection fraction to identify patients for
CRT seems outdated; however, the clinical utility of imaging-based assessments of
dyssynchrony is yet to be solidified. See pages 12 and 18.
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Lipids and Atherosclerosis
Meta-Analysis Finds Significant Benefits for Statins in the Elderly
More than 80% of all coronary events occur in patients over the age of 65 years,and it is the leading cause of death in this group.However, only 40% to 60%of
post-myocardial infarction (MI) elderly patients are taking statins because of concerns
about efficacy and side effects. Afilalo and colleagues pooled data from 9 randomized
placebo-controlled trials encompassing almost 20,000 subjects over the age of 65 years.
Rates of 5-year all-cause mortality were 16% with statins and 19% with placebo,
producing a relative risk reduction of 22% and a number needed to treat of 28. Similar
efficacy was found in reducing rates of coronary death, nonfatal MI, and stroke. This
meta-analysis shows that statins reduce all-cause mortality in the elderly and that the
magnitude of this effect is large. See page 37. See figure.
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Lipids and Atherosclerosis
Higher HDL Remains Beneficial Even When LDL is <60 mg/dl
Previous studies have suggested that low high-density lipoprotein cholesterol(HDL-C) increases coronary risk among patients with normal or elevated low-
density lipoprotein cholesterol (LDL-C), but less is known about the relationship in
patients with low LDL-C. deGoma and colleagues identified over 4,000 subjects with
LDL-C levels 60 mg/dl and then developed a primary end point of subsequent
myocardial infarction or hospitalization for ischemic heart disease (IHD). The rate of
the primary end point showed an inverse relationshipwithHDL-C,with an odds ratio
of 1.6 for those in the lowest quartile (Q) compared with the highest quartile. This
relationship persisted regardless of statin use. This study suggests that low HDL-C
increases cardiac risk, even in patients with LDL-C below 60 mg/dl. See page 49.
See figure.
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and Cardiac Surgery
Clues to the Pathogenesis of Post-CABG Atrial Fibrillation
Ithas recently been reported thatmyocardial oxidative injury leads to impaired atrialcontraction and a reduction in the atrial effective refractory period, which increases
the vulnerability to atrial fibrillation (AF). Kim and colleagues evaluated the role of
myocardial nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity
and oxidative stress in the pathogenesis of post-coronary artery bypass graft (CABG)
AF by obtaining right atrial tissue samples and blood samples before surgery and again
after reperfusion. Patients who developed AF after surgery had significantly increased
atrial NADPH oxidase activity. Plasma markers of oxidation did not identify patients
whodevelopedAF.High atrialNADPHoxidase activity is associatedwith an increased
risk of post-operative AF, suggesting that this oxidase systemmay be a keymediator in
the pathogenesis of AF after cardiac surgery. See page 68.
